Get to know more about S4i 2025

Ana Ramírez de Molina holds a PhD in Molecular Biology from the Autonomous University of Madrid and has dedicated her career to the relationship between metabolism, nutrition, and cancer. Dr. Ramírez de Molina has worked in the Translational Oncology Unit at La Paz Hospital, with extended stays at the Royal Marsden Hospital in London and the Memorial Sloan Kettering Cancer Center in New York. Following this, she became Director of R&D at TCD Pharma, where she developed novel, first-in-class antitumor drugs. In 2010, she joined IMDEA Food under the Ramón y Cajal program, where she established the Precision Nutrition in Cancer program. She has received several awards, including the John Kidney International Award and the March 8th Distinction from the Community of Madrid as an outstanding woman in science. She has led 8 national and 5 international projects, is co-inventor of 5 patents transferred to industry and promoter of two science-based start-up companies, in addition to having participated in more than 20 projects with companies and hospital networks in the Community of Madrid.